Insulin-sensitizing agent
CA 2489145 A1 · Owner: Tojo, Hideaki · Inventors: Henta, Tsutomu; Sasada, Reiko; Tojo, Hideaki
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A compound or its salt inhibiting the activity of a protein having an amino acid sequence which is the same or substantially the same as the amino acid sequence represented by SEQ ID NO:1, an extracellular domain of the above protein, an antibody, an antisense polynucleotide etc. are usable as agents , improving insulin resistance and preventives/remedies for diabetes obesity, hyperlipemia, arteriosclerosis hypertension, heart diseases and so on.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 22, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 22, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 22, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.